Valor202020212022202320242025TTMGastos comerciales, generales y administrativos97.9 M98.89 M114.76 M87.54 M156.61 M109.86 M109.86 MInvestigación y desarrollo36.46 M37.94 M38.5 M25.95 M62.41 M25.99 M25.99 MBeneficio operativo-51.04 M-67.46 M-116.2 M-76.6 M-175.24 M-110.25 M-110.25 MTotal de ingresos no operativos507 K491 K1.25 M6.96 M20.04 M3.79 M4.39 MGastos por intereses, netos de intereses capitalizados3.57 M3.82 M4.33 M4.57 M3.32 M26 K26 KIngresos no operativos, una vez deducidos los gastos por intereses-3.57 M-3.82 M-4.33 M-4.57 M21.9 M-628 K-26 KIngresos/gastos extraordinarios507 K491 K1.25 M6.96 M-5.17 M4.39 M4.39 MBeneficio antes de impuestos-54.1 M-63.66 M-192.93 M-74.2 M-138.31 M-96.7 M-96.7 MParticipación en los beneficios———————Impuestos-1.08 M-4.42 M-2.83 M452 K573 K-37.88 M-37.88 MParticipación minoritaria———————Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas-53.02 M-59.24 M-190.1 M-74.66 M-138.88 M-58.83 M-58.83 MOperaciones suspendidas—————-16.07 M-16.07 MBeneficio neto-53.02 M-59.24 M-190.1 M-74.66 M-138.88 M-74.9 M-74.9 MAjuste por dilución————000Dividendos de las acciones preferentes————46.01 M00Beneficio neto diluido atribuible a los accionistas-53.02 M-59.24 M-190.1 M-74.66 M-184.9 M-74.9 M-74.9 MBeneficio básico por acción—-0.78-2.43-0.94-0.52-0.2-0.2Beneficio por acción diluido—-0.78-2.43-0.94-0.52-0.2-0.2Número medio de acciones ordinarias—75.79 M78.31 M79.16 M353.25 M381.62 M1.52 BAcciones diluidas—75.79 M78.31 M79.16 M353.25 M381.62 M1.52 BEBITDA-35.48 M-52.12 M-109.98 M-63.93 M-181.64 M-104.3 M-99.98 MEBIT-51.04 M-67.46 M-116.2 M-76.6 M-178.55 M-110.28 M-110.28 MCosto de los ingresos———55.89 M90.17 M42.79 M42.79 MOtros costes de producción———————Amortización y depreciación (flujo de caja)15.55 M15.34 M6.22 M12.67 M-3.09 M5.97 M10.3 M
Standard BioTools Inc
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.